Condition

Autoimmune Hemolytic Anemia clinical trials and research

• 12Clinical trials
• 3Countries

Newest Autoimmune Hemolytic Anemia clinical trials

All recruiting trials (12)

• F182112 in relapsed/refractory autoimmune hemolytic anemia

  A small early study tests F182112 as a single treatment for adults with AIHA that has not responded to other therapies, to see if it’s safe and what dose works best.

  Recruiting Phase 1 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07816341

• Brain network changes in adults with anemia measured by fNIRS

  This project will use functional near-infrared spectroscopy (fNIRS) to see if brain network connections are altered in adults aged 18–65 who have anemia.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07578675

• UCAR-T cells targeting CD19 and BCMA for autoimmune blood disorders

  This treatment tests an off-the-shelf UCAR-T cell therapy that targets CD19 and BCMA to try to treat adults with antibody-driven blood disorders like ITP, autoimmune hemolytic anemia, and Evans syndrome.

  Recruiting Early Phase 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07441525

• CM336 treatment for relapsed or refractory autoimmune cytopenia

  This trial will test whether CM336, a BCMA/CD3 bispecific antibody given by injection, can help adults with relapsed or refractory autoimmune cytopenias such as ITP, AIHA, or Evans syndrome.

  Recruiting at 3 sites Phase 1/2 Keymed Biosciences Co.Ltd · Zhengzhou, Henan and 2 other locations · NCT07175493

• Evaluating brain function and psychological effects of cell therapy in autoimmune hemolytic anemia

  This study is testing how CAR T-cell therapy affects thinking and mental health in people with autoimmune hemolytic anemia to help improve their treatment and quality of life.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT06921980

• Safety evaluation of CC312 in patients with autoimmune diseases

  This study is testing a new treatment called CC312 to see if it's safe and tolerable for adults with autoimmune diseases like lupus and rheumatoid arthritis.

  Recruiting Early Phase 1 CytoCares Inc · Tianjin, China · NCT06888960

• National cohort for pediatric autoimmune cytopenia

  This study is trying to gather information about children with autoimmune blood disorders to see how they do over time and what treatments work best for them.

  Recruiting at 9 sites University Hospital, Bordeaux · Amiens and 8 other locations · NCT05937828

• Evaluation of diagnosis and treatment for autoimmune cytopenias

  This study is trying to understand how autoimmune cytopenias are diagnosed and treated, looking at different tests and treatments to see what works best for patients.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT05931718

• Using ibrutinib to treat autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia

  This study is testing if the drug ibrutinib can help adults with chronic lymphocytic leukemia who also have autoimmune hemolytic anemia feel better.

  Recruiting at 3 sites Phase 2 Gruppo Italiano Malattie EMatologiche dell'Adulto · Florence and 2 other locations · NCT05694312

• Prolonged anticoagulation for preventing blood clots in autoimmune hemolytic anemia

  This study is testing if longer use of blood thinners can help prevent blood clots in people with autoimmune hemolytic anemia.

  Recruiting Phase 2 Centre Hospitalier Universitaire Dijon · Dijon · NCT05089227

• Biological bank for patients with autoimmune cytopenia

  This study is setting up a collection of biological samples from patients with autoimmune cytopenia to help researchers learn more about these conditions and find better treatments.

  Recruiting University Hospital, Bordeaux · Pessac · NCT04005638

• Registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

  This study is collecting information from adults in France who have recently been diagnosed with immune thrombocytopenia or autoimmune hemolytic anemia to better understand these conditions and how well different treatments work in real life.

  Recruiting University Hospital, Toulouse · Toulouse · NCT02877706

Related topics

Quick answers

How many Autoimmune Hemolytic Anemia clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (6 trials), France (4 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 2, Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →